Eledoisin | CAS:69-25-0

We serve Eledoisin CAS:69-25-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Eledoisin

Chemical Name:Eledoisin
CAS.NO:69-25-0
Synonyms:Eledoisin
eledonepeptide
Eledone peptide
Eledoisin Acetate
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 1618.1±65.0 °C at 760 mmHg
Molecular Formula C54H85N13O15S
Molecular Weight 1188.396
Flash Point 932.4±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.569
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Eledoisin exhibits a wide and complex spectrum of pharmacological and physiological activities such as vasodilation, hypertension, and stimulation of extravascular smooth muscle.



Contact us for information like Eledoisin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Eledoisin Acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,eledonepeptide Use and application,eledonepeptide technical grade,usp/ep/jp grade.


Related News: Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Methyl Methoxyacetate manufacturer This is how an API becomes a medicine.3,3,3-trifluorolactic acid supplier This is how an API becomes a medicine.2-Chloro-4,6-diphenylpyrimidine vendor Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.